XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   217,117      
Beginning balance at Dec. 31, 2021 $ 6,381,689 $ 2 $ 2,034,658 $ (3,395) $ 4,350,424
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)   3,052      
Issuance of common stock upon exercise of stock options, net of repurchases 45,260   45,260    
Stock-based compensation expense 1,232,815   1,232,815    
Issuance of equity instruments as consideration for business combination (in shares)   1,663      
Issuance of equity instruments as consideration for business combination 314,356   314,356    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   4,618      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (268,746)   (268,746)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)   155      
Issuance of common stock under the ESPP 14,863   14,863    
Other 7,124   7,124    
Comprehensive loss (33,098)     (33,098)  
Net loss (2,067,948)       (2,067,948)
Ending balance (in shares) at Sep. 30, 2022   226,605      
Ending balance at Sep. 30, 2022 5,626,315 $ 2 3,380,330 (36,493) 2,282,476
Beginning balance (in shares) at Jun. 30, 2022   224,398      
Beginning balance at Jun. 30, 2022 5,813,389 $ 2 3,004,459 (18,183) 2,827,111
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)   812      
Issuance of common stock upon exercise of stock options, net of repurchases 10,318   10,318    
Stock-based compensation expense 417,721   417,721    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   1,395      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (55,613)   (55,613)    
Other 3,445   3,445    
Comprehensive loss (18,310)     (18,310)  
Net loss (544,635)       (544,635)
Ending balance (in shares) at Sep. 30, 2022   226,605      
Ending balance at Sep. 30, 2022 5,626,315 $ 2 3,380,330 (36,493) 2,282,476
Beginning balance (in shares) at Dec. 31, 2022   230,866      
Beginning balance at Dec. 31, 2022 $ 5,454,557 $ 2 3,767,686 (38,606) 1,725,475
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares) 1,883 1,840      
Issuance of common stock upon exercise of stock options, net of repurchases $ 29,384   29,384    
Stock-based compensation expense 661,510   661,510    
Issuance of equity instruments as consideration for business combination (in shares)   961      
Issuance of equity instruments as consideration for business combination 44,995   44,995    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   5,248      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (183,962)   (183,962)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)   254      
Issuance of common stock under the ESPP 12,381   12,381    
Stock-based compensation expense recognized in relation to restructuring 84,042   84,042    
Other 2,291   2,291    
Comprehensive loss (5,507)     (5,507)  
Net loss (178,566)       (178,566)
Ending balance (in shares) at Sep. 30, 2023   239,169      
Ending balance at Sep. 30, 2023 5,921,125 $ 2 4,418,327 (44,113) 1,546,909
Beginning balance (in shares) at Jun. 30, 2023   236,888      
Beginning balance at Jun. 30, 2023 5,754,703 $ 2 4,239,319 (33,792) 1,549,174
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)   660      
Issuance of common stock upon exercise of stock options, net of repurchases 11,383   11,383    
Stock-based compensation expense 233,904   233,904    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   1,621      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (68,570)   (68,570)    
Other 2,291   2,291    
Comprehensive loss (10,321)     (10,321)  
Net loss (2,265)       (2,265)
Ending balance (in shares) at Sep. 30, 2023   239,169      
Ending balance at Sep. 30, 2023 $ 5,921,125 $ 2 $ 4,418,327 $ (44,113) $ 1,546,909